Zurich Cantonal Bank
KZR

Zurich Cantonal Bank’s Kezar Life Sciences KZR Stock Holding History

Zurich Cantonal Bank’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-716
Closed -$22.4K – 2834
2023
Q1 		$22.4K Sell
716
-142
-17% -$8.22K ﹤0.01% 2732
2022
Q4 		$60.4K Sell
858
-455
-35% -$33.7K ﹤0.01% 2541
2022
Q3 		$113K Buy
1,313
+1,141
+663% +$111K ﹤0.01% 2122
2022
Q2 		$14K Sell
172
-15
-8% -$1.32K ﹤0.01% 2831
2022
Q1 		$31K Sell
187
-371
-66% -$53.2K ﹤0.01% 2605
2021
Q4 		$93K Buy
+558
New +$63K ﹤0.01% 2548

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Zurich Cantonal Bank's KZR Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 716 shares — an estimated $22.4K sold.

Zurich Cantonal Bank first reported a position in KZR in Q4 2021 and held it in 6 quarters. The position peaked at $113K in Q3 2022. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 716 Kezar Life Sciences shares in Q2 2023, an estimated $22.4K.
  • Zurich Cantonal Bank first reported a position in Kezar Life Sciences in Q4 2021 and held it in 6 quarters.
  • Zurich Cantonal Bank's Kezar Life Sciences position peaked at $113K in Q3 2022.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.